- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Remedium Lifecare's board has approved the financial results for the quarter ended June 30, 2025. On a standalone basis, the company reported a loss of ₹0.37 Cr with revenue at ₹18.37 Cr. However, consolidated results show a profit of ₹4.65 Cr on revenue of ₹113.37 Cr. This significant difference is primarily due to the inclusion of Remlife Global PTE, a subsidiary, whose financials (revenue of ₹94.99 Cr and profit of ₹5.01 Cr) are incorporated, marking the first consolidated quarterly comparison. Investors should note the strong consolidated performance driven by the subsidiary.